This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Scott E. Kamholz M.D., Ph.D.
Of Counsel
Washington +1 202 662 5339 skamholz@cov.com Download V-card

Scott Kamholz combines his experience as an Administrative Patent Judge at the U.S. Patent Trial and Appeal Board (PTAB) and background in medicine, biophysics, and engineering to advise clients in the life sciences sector on a variety of complex patent litigation matters and PTAB proceedings. Dr. Kamholz was the first PTAB judge to enter private practice after presiding over AIA trial proceedings from start to finish. He has assisted clients in dozens of PTAB proceedings since returning to private practice.

  • Represented AstraZeneca in defeating Complex Innovations’ attack on a patent covering SYMBICORT® inhalation aerosol for asthma and COPD. On July 24, 2017, the Patent Trial and Appeal Board denied institution of an IPR trial as to every challenged claim. The PTAB largely followed the arguments Covington presented in the preliminary response when determining that the petition failed to demonstrate a reasonable likelihood of prevailing at trial.

Memberships and Affiliations

  • American Intellectual Property Law Association, Member
  • Boston Intellectual Property Law Association, Member

Previous Experience

  • U. S. Patent Trial and Appeal Board (PTAB), Administrative Patent Judge